Real-time enrollment status for this moderate to severe glabellar lines clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 5:00 PM UTC
| NCT Number | NCT07427797 |
| Recruiting Status | Recruiting |
| Condition | Moderate to Severe Glabellar Lines |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Ipsen |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of August 28, 2026: Clinical trial NCT07427797 is currently recruiting participants. This phase3 study for moderate to severe glabellar lines is actively seeking new participants at 17 locations across the United States. The study is sponsored by Ipsen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07427797 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07427797 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.